Evaluation of MPM Prepared From Allogenic Bone Graft in Alveolar Cleft Closure: A Prospective Randomized Clinical Trial

Early Phase 1

• Conditions: Cleft; Alveolar Process
• Interventions: Combination Product: MPM Prepared From Allogenic Bone Graft; Other: Autogenous bone

• Registration Number: NCT03420287
• Lead Sponsor: Cairo University

Brief Summary

The aim of this trial is to figure out the efficiency of Mineralized Plasmatic Matrix prepared from allogenic bone graft on cleft alveolus and oro-nasal fistula closure, adequate bone volume and acceptable density at the site of grafting.MPM might improve the physiological properties of allogenic bone graft and facilitate its handling and application during surgical grafting.This might decrease the need of the second surgical site for harvesting autogenous bone to be grafted with its all complications and hurdles.This trial will help the practitioners in taking the decision of using the MPM prepared from allogenic bone in alveolar cleft closure or not.

Detailed Description

Alveolar bone grafting will be performed at 6 to 12 years of age as following :

Group (A):Will undergo grafting with anterior iliac crest bone,(Control group). Group (B):Will undergo grafting with Mineralized Plasmatic Matrix prepared from allogenic bone graft (study group).

In all patients, this will be the first bone graft to be placed in the alveolar cleft. All patients will be monitored clinically and radiographically (by cone beam C.T) for up to 6 months after surgery.

Study Timeline

• Status Verified: 2018-01
• Study First Submitted: 2018-01-28
• Study First Submitted QC: 2018-01-28
• Study First Posted: 2018-02-05
• Last Update Submitted: 2018-02-08
• Last Update Posted: 2018-02-12
• Study Start: 2018-04
• Primary Completion: 2019-04
• Study Completion: 2019-04

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 56

Inclusion Criteria

• Unilateral or bilateral alveolar cleft patients

Read More

Exclusion Criteria

• patients with previous failed alveolar cleft grafting procedure.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
MPM prepared from allogenic bone graft	MPM Prepared From Allogenic Bone Graft	All patients in this group will receive MPM prepared from allogenic bone graft
Autogenous bone graft group	Autogenous bone	All patients in this group will receive autogenous bone graft only

Primary Outcome Measures

Name	Time	Method
Oro-nasal Fistula	6 months	it will be assessed visually and by questionnaire with binary measuring unit (present or not).• Examination of oro-nasal Fistula will be done by using the following diagnostic criteria: 1.Air escape from the opening when patient blows his/her nose.; 2.An obvious communication between the opening and floor of the nasal cavity. 3.Unobstructed penetration of Guttapercha through the opening into the nasal cavity.; 4.Hypernasality of voice due to audible nasal air escape during speech. 5.Nasal regurgitation of fluids. 6.Food lodgement into nasal cavity with risk of rhinitis .

Secondary Outcome Measures

Name	Time	Method
C.T analysis of secondary bone grafts	6 months	it will be assessed by Chelsea Scale which radio-graphically analyzing the position of the bone tissue in relation to the teeth adjacent to the cleft and separating the images into 6 categories: A,B,C,D, E,F.; Bone grafts of types A,B and C according to the Chelsea scale were considered satisfactory, whereas the other types were considered unsatisfactory
Donor site long standing pain	6 months	it will be assessed by Numeric Rating Scale (NRS).Numeric Rating ScaleUsing the NPRS which is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of his/her pain. The common format is a horizontal bar or line.; (NRS).0 means no pain, 5 means moderate pain and 10 means worst possible pain.